Literature DB >> 10193362

CPAP therapy: outcomes and patient use.

N J Douglas1, H M Engleman.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 10193362      PMCID: PMC1765912     

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  18 in total

1.  Blood pressure and sleep apnea: results of long-term nasal continuous positive airway pressure therapy.

Authors:  J Mayer; H Becker; U Brandenburg; T Penzel; J H Peter; P von Wichert
Journal:  Cardiology       Date:  1991       Impact factor: 1.869

2.  Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients.

Authors:  J He; M H Kryger; F J Zorick; W Conway; T Roth
Journal:  Chest       Date:  1988-07       Impact factor: 9.410

3.  Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; S E Martin; I J Deary; N J Douglas
Journal:  Thorax       Date:  1997-02       Impact factor: 9.139

4.  Compliance in clinical trials of two nonbronchodilator, antiasthma medications.

Authors:  H Mawhinney; S L Spector; R A Kinsman; S C Siegel; G S Rachelefsky; R M Katz; A S Rohr
Journal:  Ann Allergy       Date:  1991-04

5.  The effect of positive reinforcement on hourly compliance in nasal continuous positive airway pressure users with obstructive sleep apnea.

Authors:  E C Fletcher; R A Luckett
Journal:  Am Rev Respir Dis       Date:  1991-05

6.  Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients.

Authors:  M Suzuki; K Otsuka; C Guilleminault
Journal:  Sleep       Date:  1993-09       Impact factor: 5.849

7.  Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea.

Authors:  I Wilcox; R R Grunstein; J A Hedner; J Doyle; F L Collins; P J Fletcher; D T Kelly; C E Sullivan
Journal:  Sleep       Date:  1993-09       Impact factor: 5.849

8.  Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea.

Authors:  N B Kribbs; A I Pack; L R Kline; P L Smith; A R Schwartz; N M Schubert; S Redline; J N Henry; J E Getsy; D F Dinges
Journal:  Am Rev Respir Dis       Date:  1993-04

9.  Nasal CPAP: an objective evaluation of patient compliance.

Authors:  M K Reeves-Hoche; R Meck; C W Zwillich
Journal:  Am J Respir Crit Care Med       Date:  1994-01       Impact factor: 21.405

10.  Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; S E Martin; I J Deary; N J Douglas
Journal:  Lancet       Date:  1994-03-05       Impact factor: 79.321

View more
  2 in total

Review 1.  Oxidative stress and oxidant signaling in obstructive sleep apnea and associated cardiovascular diseases.

Authors:  Yuichiro J Suzuki; Vivek Jain; Ah-Mee Park; Regina M Day
Journal:  Free Radic Biol Med       Date:  2006-02-02       Impact factor: 7.376

Review 2.  Sleep apnoea in the older adult : pathophysiology, epidemiology, consequences and management.

Authors:  Tamar Shochat; Giora Pillar
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.